Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation
A completed clinical trial evaluating the pharmacokinetic characteristics of intravenous Hepabig injection used to prevent hepatitis B relap…
-
CLINICAL_TRIALS withdrawal · 2016-10-18Clinical Trial Update: Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation [Phase 4]
A Phase 4 trial comparing lamivudine and entecavir for spontaneous severe acute exacerbation in chronic hepatitis B has been terminated.
-
CLINICAL_TRIALS research · 2016-10-14Clinical Trial Update: Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients [NA]
Study investigating factors that influence virological response after stopping nucleoside analogue therapy in chronic hepatitis B patients.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib [Phase 4]
This Phase 4 trial evaluates the durability of the immune response to Hepatitis B vaccination in children aged 7-9 years who were previously…
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants [Phase 3]
GlaxoSmithKline completed a Phase 3 trial comparing immunogenicity and safety of two formulations of the DTPa-HBV-IPV/Hib vaccine in healthy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants [Phase 3]
The document reports Phase 3 results evaluating lot-to-lot consistency of Tritanrix-HepB/Hib-MenAC and its non-inferiority compared with Tri…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib [Phase 4]
Phase 4 study evaluating persistence of the immune response to hepatitis B in 4-6 year-old children previously vaccinated with the hexavalen…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. [Phase 3]
A Phase 3 immunization and safety study comparing two formulations of DTPw-HBV/HIB given at birth with Hepatitis B at 2, 4, and 6 months was…
-
FDA approval · 2016-09-30FDA Approved: ENTECAVIR — Supplemental Application (AvKARE)
FDA approved a supplemental application for AvKARE's generic entecavir, authorizing its continued marketing for chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of GlaxoSmithKline's pentavalent DTPa-HBV-IPV/Hib vaccine in Indian infants across two va…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib [Phase 3]
Phase 3 booster study evaluating immunogenicity, reactogenicity, and safety of GSK's DTPw-HBV/Hib vaccine booster compared with the standard…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine [Phase 4]
This Phase 4 trial evaluates immune response approximately 5 to 6 years after receiving different formulations of GSK's Hepatitis B vaccine;…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488 [Phase 2]
Phase 2 clinical trial update evaluating a booster dose of GlaxoSmithKline's 10-valent pneumococcal conjugate vaccine and a single dose of t…
-
CLINICAL_TRIALS withdrawal · 2016-09-23Clinical Trial Update: Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks [Phase 4]
A Phase 4 trial evaluating telbivudine in Black/African American and Hispanic/Latino patients with compensated chronic hepatitis B was withd…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth [Phase 3]
This Phase 3 trial evaluated and compared the immune responses to two DTP-containing vaccines (Tritanrix-HepB/Hib-MenAC vs Tritanrix-HepB/Hi…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response [Phase 4]
Phase 4 study comparing monodose and multidose presentations of GlaxoSmithKline's Hepatitis B vaccine in terms of immune response. The trial…
-
CLINICAL_TRIALS withdrawal · 2016-09-21Clinical Trial Update: Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program
Entecavir's Early Access Program for chronic hepatitis B has ended and is no longer available.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. [Phase 3]
A Phase 3 immunogenicity and safety study of an infant meningitis vaccine given after a hepatitis B birth dose completed; the trial evaluate…
-
CLINICAL_TRIALS research · 2016-09-20Clinical Trial Update: A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High Risk
This clinical trial update describes a study evaluating strategies to interrupt mother-to-child transmission of hepatitis B virus in high-ri…
-
CLINICAL_TRIALS research · 2016-09-20Clinical Trial Update: New Strategy Study of Functional Cure of Chronic Hepatitis B [NA]
This document provides an update on a clinical trial exploring a new strategy toward achieving a functional cure for chronic hepatitis B. Th…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants [Phase 2]
A Phase 2 trial completed in healthy infants evaluated the efficacy, immune response, and safety of two doses of an oral live attenuated HRV…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's DTPa-HBV-IPV/Hib mixed vaccine and DTPa-IPV/Hib + HBV vaccines i…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a novel adjuvanted hepatitis B vaccine in healthy volunteers with HLA-DQ2; study comple…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants [Phase 3]
This Phase 3 trial in healthy infants evaluated whether giving Tritanrix-HepB/Hib-MenAC with a birth-dose Hepatitis B vaccine yields an immu…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Phase 3]
Phase 3 trial comparing an adjuvanted hepatitis B vaccine to a double dose of Engerix-B in pre- or haemodialysis patients aged 15 and older …